BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 9699534)

  • 1. Expression of fully and under-glycosylated forms of MUC1 mucin in gastric carcinoma.
    Reis CA; David L; Seixas M; Burchell J; Sobrinho-Simões M
    Int J Cancer; 1998 Aug; 79(4):402-10. PubMed ID: 9699534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucin-1-related T cell infiltration in colorectal carcinoma.
    Mulder WM; Stukart MJ; de Windt E; Wagstaff J; Scheper RJ; Bloemena E
    Cancer Immunol Immunother; 1996 Jul; 42(6):351-6. PubMed ID: 8830738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TUMOR MARKERS EXPRESSION LEVELS IN GASTRIC CANCER PATIENT'S PERIPHERAL BLOOD BY RT-PCR ASSESSMENT.
    Kawakami GDS; Pereira MA; Kubrusly MS; Carrasco AGM; Ramos MFKP; Ribeiro Júnior U
    Arq Bras Cir Dig; 2024; 36():e1789. PubMed ID: 38324850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Mucin Expression in the Diagnosis of Oesophago-Gastric Cancer: A Systematic Literature Review.
    Patel NM; Geropoulos G; Patel PH; Bhogal RH; Harrington KJ; Singanayagam A; Kumar S
    Cancers (Basel); 2023 Nov; 15(21):. PubMed ID: 37958425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered glycosylation in pancreatic cancer and beyond.
    Lumibao JC; Tremblay JR; Hsu J; Engle DD
    J Exp Med; 2022 Jun; 219(6):. PubMed ID: 35522218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Family-based exome sequencing combined with linkage analyses identifies rare susceptibility variants of MUC4 for gastric cancer.
    Choi YJ; Ohn JH; Kim N; Kim W; Park K; Won S; Sael L; Shin CM; Lee SM; Lee S; An HJ; Jang DM; Han BW; Lee HS; Kang SJ; Kim JS; Lee DH
    PLoS One; 2020; 15(7):e0236197. PubMed ID: 32701958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esophageal, gastric and colorectal cancers: Looking beyond classical serological biomarkers towards glycoproteomics-assisted precision oncology.
    Fernandes E; Sores J; Cotton S; Peixoto A; Ferreira D; Freitas R; Reis CA; Santos LL; Ferreira JA
    Theranostics; 2020; 10(11):4903-4928. PubMed ID: 32308758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycosylation and its implications in breast cancer.
    Scott DA; Drake RR
    Expert Rev Proteomics; 2019 Aug; 16(8):665-680. PubMed ID: 31314995
    [No Abstract]   [Full Text] [Related]  

  • 9. Glycosylation in health and disease.
    Reily C; Stewart TJ; Renfrow MB; Novak J
    Nat Rev Nephrol; 2019 Jun; 15(6):346-366. PubMed ID: 30858582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicellular Human Gastric-Cancer Spheroids Mimic the Glycosylation Phenotype of Gastric Carcinomas.
    Balmaña M; Mereiter S; Diniz F; Feijão T; Barrias CC; Reis CA
    Molecules; 2018 Oct; 23(11):. PubMed ID: 30380716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single domain based bispecific antibody, Muc1-Bi-1, and its humanized form, Muc1-Bi-2, induce potent cancer cell killing in muc1 positive tumor cells.
    Li Y; Zhou C; Li J; Liu J; Lin L; Li L; Cao D; Li Q; Wang Z
    PLoS One; 2018; 13(1):e0191024. PubMed ID: 29357376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucin-Type O-Glycosylation in Gastric Carcinogenesis.
    Duarte HO; Freitas D; Gomes C; Gomes J; Magalhães A; Reis CA
    Biomolecules; 2016 Jul; 6(3):. PubMed ID: 27409642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MUC1 Immunohistochemical Expression as a Prognostic Factor in Gastric Cancer: Meta-Analysis.
    Wang XT; Kong FB; Mai W; Li L; Pang LM
    Dis Markers; 2016; 2016():9421571. PubMed ID: 27190429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycomic Approaches for the Discovery of Targets in Gastrointestinal Cancer.
    Mereiter S; Balmaña M; Gomes J; Magalhães A; Reis CA
    Front Oncol; 2016; 6():55. PubMed ID: 27014630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycosylation in cancer: mechanisms and clinical implications.
    Pinho SS; Reis CA
    Nat Rev Cancer; 2015 Sep; 15(9):540-55. PubMed ID: 26289314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia Up-Regulates Galectin-3 in Mammary Tumor Progression and Metastasis.
    de Oliveira JT; Ribeiro C; Barros R; Gomes C; de Matos AJ; Reis CA; Rutteman GR; Gärtner F
    PLoS One; 2015; 10(7):e0134458. PubMed ID: 26222311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucin 1 gene (MUC1) and gastric-cancer susceptibility.
    Saeki N; Sakamoto H; Yoshida T
    Int J Mol Sci; 2014 May; 15(5):7958-73. PubMed ID: 24810688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical applications of nucleic acid aptamers in cancer.
    Pei X; Zhang J; Liu J
    Mol Clin Oncol; 2014 May; 2(3):341-348. PubMed ID: 24772298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An inverse relationship between the expression of the gastric tumor suppressor RUNX3 and infection with Helicobacter pylori in gastric epithelial dysplasia.
    Chung WC; Jung SH; Joo KR; Kim MJ; Youn GJ; Kim Y; Lee JS; Lee H; Jung JH; Lee YK
    Gut Liver; 2013 Nov; 7(6):688-95. PubMed ID: 24312710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-sensitivity analytical approaches for the structural characterization of glycoproteins.
    Alley WR; Mann BF; Novotny MV
    Chem Rev; 2013 Apr; 113(4):2668-732. PubMed ID: 23531120
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.